Smart scans guide tailored chemo for HER2+ breast cancer
NCT ID NCT07527806
First seen Apr 19, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This study tests whether using a special PET scan (HER2-PET/CT) can help doctors personalize chemotherapy for people with early-stage HER2-positive breast cancer. After two cycles of treatment, the scan results will guide whether to intensify or reduce therapy. The goal is to improve the chance of eliminating all cancer before surgery while avoiding unnecessary side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.